38 RITONAVIR BOOSTING OF LOW DOSE RG7227/ITMN-191, HCV NS3/4A PROTEASE INHIBITOR, RESULTS IN ROBUST REDUCTION IN HCV RNA AT LOWER EXPOSURES THAN PROVIDED BY UNBOOSTED REGIMENS

Authors :: Y. Zhang
Linda Chang
Regine Rouzier
Andrzej Horban
P. Sampeur
E.J. Gane
Patrick F. Smith
Isabel Najera
Jonathan Q. Tran
Alicja Wiercińska-Drapało
Nancy S. Shulman
Catherine A.M. Stedman
Source :: Journal of Hepatology. 52:S16-S17
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: Boosting (doping)
Hepatology
business.industry
Low dose
medicine
Protease inhibitor (pharmacology)
Ritonavir
business
Virology
medicine.drug

Full Text Access

Tools